Seeking Alpha

Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation

Study is evaluating whether Triplex is safe and effective in improving the outcomes of liver transplant recipients MIAMI, May 14, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (“Fortress”), an ...
Seeking Alpha

Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT

Study is the first randomized, controlled trial examining a vaccine’s effectiveness in controlling CMV in recipients of HSCT from vaccinated donors Encouraging pilot study results demonstrated the ...
Business Wire

Triplex Meets Primary Endpoint in Phase 2 Clinical Trial, Reduces Rate of Cytomegalovirus (CMV) Complications in Transplant Recipients by 50 Percent

First prophylactic vaccine to demonstrate proof of concept for CMV control independent of human leukocyte antigen (HLA) status in stem cell transplant recipients DUARTE, Calif.--(BUSINESS WIRE)--City ...
ABC7 San Francisco

1 hurt, 14 displaced in 2-alarm triplex fire in Oakland

OAKLAND, Calif. -- A two-alarm fire at a triplex near Oakland's San Antonio Park that displaced 14 adults early this morning has been deemed suspicious, a fire battalion chief said. Firefighters ...
NBC Bay Area

One Injured, 14 Displaced in 2-Alarm Triplex Fire in Oakland

A two-alarm fire at a triplex near Oakland's San Antonio Park that displaced 14 adults early Sunday morning has been deemed suspicious, a fire battalion chief said. Firefighters responded to a report ...